Tennessee bills · 114th Regular Session (2025-2026)

Tennessee SB 436

Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

1. Introduced
2. In committee
3. Passed Senate
4. Passed House
5. To Governor
6. Became law

Sponsors

• Reeves

Summary

Text versions

• Current Version
• Amendment SA0236
• Amendment HA0140

Roll-call votes

State vote data last updated Oct 27, 2026, 8:04 AM.

Actions

• Apr 28, 2025 · Legislature
  Comp. became Pub. Ch. 206
• Mar 31, 2025 · Senate
  Companion House Bill substituted
• Mar 28, 2025 · Senate
  Placed on Senate Regular Calendar for 3/31/2025
• Mar 25, 2025 · Senate
  Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
• Mar 19, 2025 · Senate
  Placed on Senate Commerce and Labor Committee calendar for 3/25/2025
• Mar 18, 2025 · Senate
  Action deferred in Senate Commerce and Labor Committee to 3/25/2025
• Mar 13, 2025 · Senate
  Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
• Mar 11, 2025 · Senate
  Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
• Feb 12, 2025 · Senate
  Passed on Second Consideration, refer to Senate Commerce and Labor Committee
• Feb 10, 2025 · Senate
  Introduced, Passed on First Consideration
• Jan 28, 2025 · Senate
  Filed for introduction